About
About this Poster:
Efpeglenatide, a long-acting glucagon-like peptide-1 receptor agonist in development for type 2 diabetes, induces weight loss through satiety and reduced food intake. Studies in Sprague Dawley rats investigated how peripheral and central mechanisms contribute to the anorectic effects of efpeglenatide.
![Investigations into Tissue Distribution and Inhibition of Food Consumption with Efpeglenatide thumbnail](https://prosciento.com/wp-content/uploads/2022/01/poster-20.png)